Nevada Medicaid Operations Transmittal Letter About Implementation of Preferred Drug List

March 10, 2010 On June 30, 2010, brand-name atypical and typical antipsychotic medications to treat mental illness, anticonvulsant medications, and anti-diabetic medications will be added to Nevada's Medicaid preferred drug list (PDL). People taking these medications will have continued access; No prior authorization will be required if the patient maintains continuous Medicaid eligibility and continues to take the medication. After June 30, 2010, prior authorization for new clinical uses will be required. New patients must demonstrate therapeutic failure on one preferred atypical or typical antipsychotic, anticonvulsant, and anti-diabetic medication, before use of a non- preferred medication . . .